This compound is primarily utilized in pharmaceutical research and development as a key intermediate in the synthesis of biologically active molecules. It is often employed in the creation of potential drug candidates targeting various diseases, particularly those involving enzyme inhibition or receptor modulation. Its structure, featuring a piperazine core and a chloropyridazine moiety, makes it valuable for designing compounds with specific binding properties. Researchers leverage its sulfonyl and carboxylate functional groups to enhance solubility and bioavailability in drug formulations. Additionally, it is used in medicinal chemistry studies to explore structure-activity relationships (SAR) for optimizing therapeutic efficacy and reducing side effects.